IMR Press / EJGO / Volume 41 / Issue 2 / DOI: 10.31083/j.ejgo.2020.02.5138
Open Access Original Research
Clinical significance of β-catenin, hTERT, p53, and Wnt7A as biomarkers for ovarian cancer
Show Less
1 Department of Obstetrics and Gynaecology, Gauhati Medical College, Assam, India
2 Department of Bioengineering & Technology, Institute of Science and Technology, Gauhati University, Assam, India
3 North East Cancer Hospital and Research Institute, Jorabat, Guwahati, Assam, India
Eur. J. Gynaecol. Oncol. 2020, 41(2), 181–187; https://doi.org/10.31083/j.ejgo.2020.02.5138
Published: 15 April 2020
Abstract

Aim: The aim of the present study was to examine the association of β-catenin, hTERT, p53, and Wnt7A with the clinicopathologic features of epithelial ovarian carcinoma (EOC). Materials and Methods: By using qRT-PCR method, the authors attempted to elucidate the diagnostic evaluation of β-catenin, hTERT, p53, and Wnt7AmRNA for ovarian malignancy. Results: It was observed that, compared to the healthy control group, the expression levels of β-catenin, hTERT, p53, and Wnt7A were upregulated in all the ovarian cancer cases. The current study indicated that individual expression of β-catenin, hTERT and Wnt7A did not significantly correlate with patients’ clinicopathological parameters. However, expression of p53 significantly correlated with the FIGO Stage (p < 0.001) and histological grade (p < 0.001) of EOC patients. Conclusions: The mRNA expression levels of β-catenin, hTERT, p53, and Wnt7A were upregulated in all the ovarian cancer cases, compared to the healthy controls, which signifies their roles as ovarian cancer biomarkers. These biomarkers can be recognized as a potential important target for detection and anticancer therapies for ovarian cancer cases.

Keywords
Wnt7A
p53
β-catenin
hTERT
Clinicopathological
Figures
Figure 1.
Share
Back to top